1.New inhibitors targeting bacterial RNA polymerase.
Journal of Zhejiang University. Medical sciences 2019;48(1):44-49
Rifamycins, a group of bacterial RNA polymerase inhibitors, are the firstline antimicrobial drugs to treat tuberculosis. In light of the emergence of rifamycinresistant bacteria, development of new RNA polymerase inhibitors that kill rifamycinresistant bacteria with high bioavailability is urgent. Structural analysis of bacterial RNA polymerase in complex with inhibitors by crystallography and cryo-EM indicates that RNA polymerase inhibitors function through five distinct molecular mechanisms:inhibition of the extension of short RNA; competition with substrates; inhibition of the conformational change of the'bridge helix'; inhibition of clamp opening;inhibition of clamp closure. This article reviews the research progress of these five groups of RNA polymerase inhibitors to provide references for the modification of existing RNA polymerase inhibitors and the discovery of new RNA polymerase inhibitors.
Antitubercular Agents
;
therapeutic use
;
Bacteria
;
drug effects
;
enzymology
;
DNA-Directed RNA Polymerases
;
metabolism
;
Drug Discovery
;
trends
;
Drug Resistance, Bacterial
;
Enzyme Activation
;
drug effects
;
Enzyme Inhibitors
;
pharmacology
;
Humans
;
RNA, Bacterial
;
Tuberculosis
;
drug therapy
;
enzymology
2.Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach.
Damini SOOD ; Neeraj KUMAR ; Aarushi SINGH ; Meena Kishore SAKHARKAR ; Vartika TOMAR ; Ramesh CHANDRA
Genomics & Informatics 2018;16(3):44-51
Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones: lomefloxacin, norfloxacin, ciprofloxacin, and ofloxacin have been studied. The objective of this study was to analyze the antibacterial characteristics of the different fluoroquinolones. Also, the pharmacological properties of the compounds including the Lipinski rule of five, absorption, distribution, metabolism, and excretion, LD50, drug likeliness, and toxicity were evaluated. We found that among all four FQ molecules, ofloxacin showed the highest antibacterial activity through in silico assays with a strong interaction (−38.52 kJ/mol) with the antibacterial target protein (topoisomerase-II DNA gyrase enzyme). The pharmacological and pharmacokinetic analysis also showed that the compounds ciprofloxacin, ofloxacin, lomefloxacin and norfloxacin have good pharmacological properties. Notably, ofloxacin was found to possess an IGC50 (concentration needed to inhibit 50% growth) value of 0.286 μg/L against the Tetrahymena pyriformis protozoa. It also tested negative for the Ames toxicity test, showing its non-carcinogenic character.
Absorption
;
Anti-Bacterial Agents
;
Bacterial Infections
;
Ciprofloxacin
;
Computer Simulation
;
DNA Gyrase
;
Fluoroquinolones*
;
Humans
;
Lethal Dose 50
;
Metabolism
;
Norfloxacin
;
Ofloxacin
;
Tetrahymena pyriformis
;
Toxicity Tests
;
Veterinary Medicine
3.ToxR Is Required for Biofilm Formation and Motility of Vibrio Parahaemolyticus.
Long CHEN ; Yue QIU ; Hao TANG ; Ling Fei HU ; Wen Hui YANG ; Xiao Jue ZHU ; Xin Xiang HUANG ; Tang WANG ; Yi Quan ZHANG
Biomedical and Environmental Sciences 2018;31(11):848-850
Bacterial Proteins
;
genetics
;
metabolism
;
Biofilms
;
DNA-Binding Proteins
;
genetics
;
metabolism
;
Flagella
;
genetics
;
metabolism
;
Gene Expression Regulation, Bacterial
;
Transcription Factors
;
genetics
;
metabolism
;
Vibrio parahaemolyticus
;
cytology
;
genetics
;
growth & development
;
physiology
4.Change of bacterial community structure during cellulose degradation by the microbial consortium.
Shiqi AI ; Yiquan ZHAO ; Zhiyuan SUN ; Yamei GAO ; Lei YAN ; Hongzhi TANG ; Weidong WANG
Chinese Journal of Biotechnology 2018;34(11):1794-1808
In order to clarify dynamic change of microbial community composition and to identify key functional bacteria in the cellulose degradation consortium, we studied several aspects of the biodegradation of filter papers and rice straws by the microbial consortium, the change of substrate degradation, microbial biomass and pH of fermentation broth. We extracted total DNA of the microbial consortium in different degradation stages for high-throughput sequencing of amplicons of bacterial 16 S rRNA genes. Based on the decomposition characteristics test, we defined the 12th, 72nd and 168th hours after inoculation as the initial stage, peak stage and end stage of degradation, respectively. The microbial consortium was mainly composed of 1 phylum, 2 classes, 2 orders, 7 families and 11 genera. With cellulose degradation, bacteria in the consortium showed different growth trends. The relative abundance of Brevibacillus and Caloramator decreased gradually. The relative abundance of Clostridium, Bacillus, Geobacillus and Cohnella increased gradually. The relative abundance of Ureibacillus, Tissierella, Epulopiscium was the highest in peak stage. The relative abundance of Paenibacillus and Ruminococcus did not change obviously in each stage. Above-mentioned 11 main genera all belonged to Firmicutes, which are thermophilic, broad pH adaptable and cellulose or hemicellulose degradable. During cellulose degradation by the microbial consortium, aerobic bacteria were dominant functional bacteria in the initial stage. However, the relative abundance of anaerobic bacteria increased gradually in middle and end stage, and replaced aerobic bacteria to become main bacteria to degrade cellulose.
Bacteria
;
classification
;
metabolism
;
Biodegradation, Environmental
;
Cellulose
;
metabolism
;
DNA, Bacterial
;
genetics
;
Microbial Consortia
;
RNA, Ribosomal, 16S
;
genetics
5.First Case Report of Bacteremia Due to Catabacter hongkongensis in a Korean Patient.
Yong Jun CHOI ; Eun Jeong WON ; Soo Hyun KIM ; Myung Geun SHIN ; Jong Hee SHIN ; Soon Pal SUH
Annals of Laboratory Medicine 2017;37(1):84-87
No abstract available.
Aged
;
Anti-Bacterial Agents/pharmacology/therapeutic use
;
Cefotaxime/analogs & derivatives/therapeutic use
;
Cholangiopancreatography, Endoscopic Retrograde
;
Gallstones/surgery
;
Gram-Negative Anaerobic Bacteria/drug effects/genetics/*isolation & purification
;
Gram-Negative Bacterial Infections/*diagnosis/drug therapy/microbiology
;
Humans
;
Male
;
Metronidazole/therapeutic use
;
Microbial Sensitivity Tests
;
RNA, Ribosomal, 16S/chemistry/genetics/metabolism
;
Sequence Analysis, DNA
;
Tomography, X-Ray Computed
6.Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.
Mark D GONZALEZ ; Allison R MCMULLEN ; Meghan A WALLACE ; Matthew P CROTTY ; David J RITCHIE ; Carey Ann D BURNHAM
Annals of Laboratory Medicine 2017;37(2):174-176
No abstract available.
Anti-Bacterial Agents/*pharmacology
;
Azabicyclo Compounds/*pharmacology
;
Bacterial Proteins/genetics
;
Ceftazidime/*pharmacology
;
Cephalosporins/*pharmacology
;
DNA, Bacterial/genetics/metabolism
;
Drug Resistance, Bacterial/*drug effects
;
Gram-Negative Bacteria/drug effects/*isolation & purification
;
Humans
;
Microbial Sensitivity Tests
;
Penicillanic Acid/*analogs & derivatives/pharmacology
;
Pseudomonas aeruginosa/drug effects/isolation & purification
;
Real-Time Polymerase Chain Reaction
7.Structural insights into glutathione-mediated activation of the master regulator PrfA in Listeria monocytogenes.
Yong WANG ; Han FENG ; Yalan ZHU ; Pu GAO
Protein & Cell 2017;8(4):308-312
Bacterial Proteins
;
chemistry
;
genetics
;
metabolism
;
DNA, Bacterial
;
chemistry
;
genetics
;
metabolism
;
Gene Expression Regulation, Bacterial
;
physiology
;
Glutathione
;
metabolism
;
Listeria monocytogenes
;
chemistry
;
genetics
;
metabolism
;
Peptide Termination Factors
;
chemistry
;
genetics
;
metabolism
8.Markerless DNA deletion based on Red recombination and in vivo I-Sec I endonuclease cleavage in Escherichia coli chromosome.
Meiqin ZHU ; Jian YU ; Changlin ZHOU ; Hongqing FANG
Chinese Journal of Biotechnology 2016;32(1):114-126
Red-based recombineering has been widely used in Escherichia coli genome modification through electroporating PCR fragments into electrocompetent cells to replace target sequences. Some mutations in the PCR fragments may be brought into the homologous regions near the target. To solve this problem in markeless gene deletion we developed a novel method characterized with two-step recombination and a donor plasmid. First, generated by PCR a linear DNA cassette which comprises a I-Sec I site-containing marker gene and homologous arms was electroporated into cells for marker-substitution deletion of the target sequence. Second, after a donor plasmid carrying the I-Sec I site-containing fusion homologous arm was chemically transformed into the marker-containing cells, the fusion arms and the marker was simultaneously cleaved by I-Sec I endonuclease and the marker-free deletion was stimulated by double-strand break-mediated intermolecular recombination. Eleven nonessential regions in E. coli DH1 genome were sequentially deleted by our method, resulting in a 10.59% reduced genome size. These precise deletions were also verified by PCR sequencing and genome resequencing. Though no change in the growth rate on the minimal medium, we found the genome-reduced strains have some alteration in the acid resistance and for the synthesis of lycopene.
Chromosomes, Bacterial
;
genetics
;
DNA
;
Endonucleases
;
metabolism
;
Escherichia coli
;
genetics
;
Genetic Engineering
;
methods
;
Recombination, Genetic
;
Sequence Deletion
9.Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital.
Do Kyun KIM ; Hyoung Sun KIM ; Naina PINTO ; Jongsoo JEON ; Roshan D'SOUZA ; Myung Sook KIM ; Jun Yong CHOI ; Dongeun YONG ; Seok Hoon JEONG ; Kyungwon LEE
Annals of Laboratory Medicine 2016;36(2):162-165
Carbapenemase-producing organisms (CPO) are rapidly disseminating worldwide, and their presence in tertiary care hospitals poses a significant threat to the management of nosocomial infections. There is a need to control CPO, especially in intensive care unit (ICU) patients, because these organisms are resistant to most beta-lactam antibiotics and are easily transmitted. At present, the identification of CPO is time-consuming; hence, this study focused on the use of the Xpert CARBA-R assay (Cepheid, USA) to determine intestinal colonization rates of CPO in patients admitted to the ICU of a tertiary care hospital in Korea. Forty clinical stool samples were collected and inoculated both in a CARBA-R cartridge and in conventional culture plates. The CARBA-R assay required only ~one hour to screen CPO, while the time required for conventional culture was over three days. We also found that the prevalences of intestinal colonization by carbapenem-resistant organisms and Enterobacteriaceae were 17.5% (7 out of 40) and 7.5% (3 out of 40), respectively. Among the colonizing strains, three that contained carbapenemase, including Klebsiella pneumonia carbapenemase (KPC), and imipenem (IMP) and Verona integron-mediated metallo-beta-lactamase (VIM) were found. With its convenience, the Xpert CARBA-R assay can be included in CPO surveillance strategies.
Anti-Bacterial Agents/pharmacology
;
Bacterial Proteins/*genetics/metabolism
;
DNA, Bacterial/analysis
;
Drug Resistance, Multiple, Bacterial/genetics
;
Enterobacteriaceae/drug effects/genetics/*isolation & purification
;
Feces/microbiology
;
Humans
;
Imipenem/pharmacology
;
Intensive Care Units
;
Klebsiella pneumoniae/drug effects/genetics/*isolation & purification
;
Reagent Kits, Diagnostic
;
Real-Time Polymerase Chain Reaction
;
Republic of Korea
;
Tertiary Healthcare
;
beta-Lactamases/*genetics/metabolism
10.Effect of Decitabine on DKK1 Gene Demethylation in Leukemia Cells.
Feng-Zhi LIU ; Ling HE ; Ji-Shi WANG ; Song ZHANG ; Hong-Qian ZHU
Journal of Experimental Hematology 2016;24(1):56-60
OBJECTIVETo explore the effect of decitabine on Dickkopf-1 (DKK1) gene expression level and its downstream Wnt signaling pathway in acute myeloid leukemia (AML) cell line HL-60.
METHODSFlow cytometry and DNA ladder analysis were performed to detect apoptosis in HL-60 cell treated with different concentration of decitabine. Methylation-specific polymerase chain reaction (MS-PCR) was used to examine the methylation status of DKK1 gene. The expressions of mRNA and protein were determined by qRT-PCR and Western blot, respectively.
RESULTSFlow cytometric detection showed that after treating HL-60 cell line with decitabine of different concentrations for 48 h, the early apoptosis of HL-60 cells increased significantly as compared with control group (P < 0.05). DNA ladder analysis showed that the DNA ladder and demethylation of DKK1 gene appeared. RT-PCR and Western blot showed that the expressions of mRNA and protein increased. The protein expressions of β-catenin and C-MYC decreased.
CONCLUSIONThe decitabine can promote the apoptosis of HL-60 cells throngh demethylation of DDK1 gene and inhibition of Wnt signalling pathway.
Apoptosis ; Azacitidine ; analogs & derivatives ; pharmacology ; DNA Methylation ; Gene Expression Regulation, Bacterial ; Genes, myc ; HL-60 Cells ; drug effects ; Humans ; Intercellular Signaling Peptides and Proteins ; metabolism ; Leukemia, Myeloid, Acute ; pathology ; RNA, Messenger ; Wnt Signaling Pathway ; beta Catenin ; metabolism

Result Analysis
Print
Save
E-mail